109 related articles for article (PubMed ID: 35435120)
1. CircSETD3 (hsa_circ_0000567) inhibits proliferation and induces apoptosis in cholangiocarcinoma cells via downregulation of microRNA-421 expression.
Xiong W; Zhang A; Xiao X; Liu W
Bioengineered; 2022 Apr; 13(4):10191-10201. PubMed ID: 35435120
[TBL] [Abstract][Full Text] [Related]
2. Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression.
Sun J; Feng M; Zou H; Mao Y; Yu W
Histol Histopathol; 2023 Oct; 38(10):1129-1143. PubMed ID: 36331285
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.
Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979
[TBL] [Abstract][Full Text] [Related]
4. Exosomal circ_0037104 derived from Hu-MSCs inhibits cholangiocarcinoma progression by sponging miR-620 and targeting AFAP1.
Yuan Z; Xiong B; Liu L; Lu Y; Liu Y; Wang G; Qian Y; Diao B; Tu M
J Biochem Mol Toxicol; 2024 Feb; 38(2):e23656. PubMed ID: 38348717
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis.
Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W
Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421
[TBL] [Abstract][Full Text] [Related]
6. MiR-149-5p inhibits cell proliferation, promotes cell apoptosis and retards cell cycle of IL-22-stimulated HaCaT and NHEK keratinocytes via regulating PDE4D.
Hu W; Jiang Y; Wen C; Zeng Y; Jia M
Cytokine; 2023 Apr; 164():156123. PubMed ID: 36796259
[TBL] [Abstract][Full Text] [Related]
7. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients.
Chen T; Wang H; Yan H
Cell Cycle; 2022 Oct; 21(19):2079-2090. PubMed ID: 35670491
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of microRNA-205-5p promotes cholangiocarcinoma growth by reducing expression of homeodomain-interacting protein kinase 3.
Mon AM; Intuyod K; Klungsaeng S; Jusakul A; Pongking T; Lert-Itthiporn W; Luvira V; Pairojkul C; Plengsuriyakarn T; Na-Bangchang K; Pinlaor S; Pinlaor P
Sci Rep; 2023 Dec; 13(1):22444. PubMed ID: 38105269
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma.
Zhao W; Zhao J; Li K; Hu Y; Yang D; Tan B; Shi J
Lab Invest; 2023 Sep; 103(9):100193. PubMed ID: 37285922
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis.
Wang G; Gao X; Sun Z; He T; Huang C; Li S; Long H
Anticancer Drugs; 2023 Oct; 34(9):1002-1009. PubMed ID: 36727735
[TBL] [Abstract][Full Text] [Related]
11. JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis.
Lei S; Cao W; Zeng Z; Zhang Z; Jin B; Tian Q; Wu Y; Zhang T; Li D; Hu C; Lan J; Zhang J; Chen T
Cell Death Dis; 2022 Nov; 13(11):967. PubMed ID: 36400758
[TBL] [Abstract][Full Text] [Related]
12. L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression.
Zhu B; Zheng J; Hong G; Bai T; Qian W; Liu J; Hou X
Chin Med J (Engl); 2022 Dec; 135(24):2956-2967. PubMed ID: 36728287
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.
Duwe L; Munoz-Garrido P; Lewinska M; Lafuente-Barquero J; Satriano L; Høgdall D; Taranta A; Nielsen BS; Ghazal A; Matter MS; Banales JM; Aldana BI; Gao YT; Marquardt JU; Roberts LR; Oliveira RC; Koshiol J; O'Rourke CJ; Andersen JB
J Hepatol; 2023 Feb; 78(2):364-375. PubMed ID: 36848245
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic and Anti-metastatic Effects of Atractylodes lancea (Thunb.) DC. in a Hamster Model of Cholangiocarcinoma.
Sonsomnuek P; Tarasuk M; Plengsuriyakarn T; Boonprasert K; Na-Bangchang K
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3093-3101. PubMed ID: 36172672
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA hsa_circ_0004381 Promotes Neuronal Injury in Parkinson's Disease Cell Model by miR-185-5p/RAC1 Axis.
Zhang H; Wang C; Zhang X
Neurotox Res; 2022 Aug; 40(4):1007-1019. PubMed ID: 35726081
[TBL] [Abstract][Full Text] [Related]
16. Tumor Cell-Derived Extracellular Vesicles Promote the Growth, Metastasis and Chemoresistance in Cholangiocarcinoma by Delivering microRNA-210 to Downregulate RECK.
Fu Y; Liu Y; Liu K; Tan L
Mol Biotechnol; 2023 Jul; 65(7):1151-1164. PubMed ID: 36454533
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation.
Chen Y; Xu X; Wang Y; Zhang Y; Zhou T; Jiang W; Wang Z; Chang J; Liu S; Chen R; Shan J; Wang J; Wang Y; Li C; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):265. PubMed ID: 37821935
[TBL] [Abstract][Full Text] [Related]
18. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
[TBL] [Abstract][Full Text] [Related]
19. The real-time dynamic monitoring of microRNA function in cholangiocarcinoma.
Chen X; Chen J; Liu X; Guo Z; Sun X; Zhang J
PLoS One; 2014; 9(6):e99431. PubMed ID: 24918778
[TBL] [Abstract][Full Text] [Related]
20. Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42.
Liu S; Guan C; Sha X; Gao X; Zou X; Yang C; Zhang X; Zhong X; Jiang X
Cell Signal; 2024 Jun; 118():111141. PubMed ID: 38492624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
